Click here for program information.
November 4th, 2026Why has ovarian cancer screening eluded researchers for 4 decades?Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD. Read more
November 3rd, 2026Lisa Taylor-Swanson, PhD, on integrative group visits for menopauseLisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.Read more
November 3rd, 2026Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depressionPeter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.Read more
November 3rd, 2026Top video interviews from The Menopause Society 2026 Annual MeetingA recap of the top video interviews from Contemporary OB/GYN's coverage of The Menopause Society 2026 Annual Meeting in San Diego.Read more
November 2nd, 2026Reactions to FDA's boxed warning removals for menopausal hormone therapySusan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.Read more
November 2nd, 2026FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosisThe FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.Read more
November 2nd, 2026Top headlines in women's health from October 2026A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.Read more
October 30th, 2026Chrisandra Shufelt, MD, on cardiovascular risk assessment and menopause careChrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause.Read more